| 1 | 1 | | 1 of 1 |
|---|
| 2 | 2 | | HOUSE DOCKET, NO. 2992 FILED ON: 1/16/2025 |
|---|
| 3 | 3 | | HOUSE . . . . . . . . . . . . . . . No. 193 |
|---|
| 4 | 4 | | The Commonwealth of Massachusetts |
|---|
| 5 | 5 | | _________________ |
|---|
| 6 | 6 | | PRESENTED BY: |
|---|
| 7 | 7 | | Marcus S. Vaughn |
|---|
| 8 | 8 | | _________________ |
|---|
| 9 | 9 | | To the Honorable Senate and House of Representatives of the Commonwealth of Massachusetts in General |
|---|
| 10 | 10 | | Court assembled: |
|---|
| 11 | 11 | | The undersigned legislators and/or citizens respectfully petition for the adoption of the accompanying bill: |
|---|
| 12 | 12 | | An Act to improve warning labels on THC products. |
|---|
| 13 | 13 | | _______________ |
|---|
| 14 | 14 | | PETITION OF: |
|---|
| 15 | 15 | | NAME:DISTRICT/ADDRESS :DATE ADDED:Marcus S. Vaughn9th Norfolk1/16/2025 1 of 2 |
|---|
| 16 | 16 | | HOUSE DOCKET, NO. 2992 FILED ON: 1/16/2025 |
|---|
| 17 | 17 | | HOUSE . . . . . . . . . . . . . . . No. 193 |
|---|
| 18 | 18 | | By Representative Vaughn of Wrentham, a petition (accompanied by bill, House, No. 193) of |
|---|
| 19 | 19 | | Marcus S. Vaughn relative to warning labels on products containing cannabis. Cannabis Policy. |
|---|
| 20 | 20 | | The Commonwealth of Massachusetts |
|---|
| 21 | 21 | | _______________ |
|---|
| 22 | 22 | | In the One Hundred and Ninety-Fourth General Court |
|---|
| 23 | 23 | | (2025-2026) |
|---|
| 24 | 24 | | _______________ |
|---|
| 25 | 25 | | An Act to improve warning labels on THC products. |
|---|
| 26 | 26 | | Be it enacted by the Senate and House of Representatives in General Court assembled, and by the authority |
|---|
| 27 | 27 | | of the same, as follows: |
|---|
| 28 | 28 | | 1 SECTION 1. Subsection (a1/2) of section 4 of chapter 94G of the General Laws is hereby |
|---|
| 29 | 29 | | 2amended by striking clause (xxvi) and inserting in place thereof the following: |
|---|
| 30 | 30 | | 3 (xxvi) requirements for the labeling of a package containing marijuana or marijuana |
|---|
| 31 | 31 | | 4products that shall, at a minimum, include: (1) a symbol or easily recognizable mark issued by |
|---|
| 32 | 32 | | 5the commission that indicates the package contains marijuana or a marijuana product; (2) a |
|---|
| 33 | 33 | | 6symbol or other easily recognizable mark issued by the commission on the package indicating to |
|---|
| 34 | 34 | | 7children that the product is harmful to children; (3) the name and contact information of the |
|---|
| 35 | 35 | | 8marijuana cultivator or the marijuana product manufacturer who produced the marijuana or |
|---|
| 36 | 36 | | 9marijuana product; (4) the results of sampling, testing and analysis conducted by a licensed |
|---|
| 37 | 37 | | 10independent testing laboratory; (5) a seal certifying the marijuana meets such testing standards; |
|---|
| 38 | 38 | | 11(6) a unique batch number identifying the production batch associated with manufacturing, |
|---|
| 39 | 39 | | 12processing, and cultivating; (7) a list of ingredients and possible allergens; (8) in bold, the |
|---|
| 40 | 40 | | 13amount of delta-nine-tetrahydrocannabinol (Δ9–THC) in the package and in each serving of a 2 of 2 |
|---|
| 41 | 41 | | 14marijuana product as expressed in absolute terms and as a percentage of volume; (9) the number |
|---|
| 42 | 42 | | 15of servings in a package if there are multiple servings; (10) a use-by date, if applicable; and (11) |
|---|
| 43 | 43 | | 16the following statement, including capitalization: ''This product has not been analyzed or |
|---|
| 44 | 44 | | 17approved by the FDA. There is limited information on the side effects of using this product, and |
|---|
| 45 | 45 | | 18there may be associated health risks. Marijuana use during pregnancy and breast-feeding may |
|---|
| 46 | 46 | | 19pose potential harms. It is against the law to drive or operate machinery when under the |
|---|
| 47 | 47 | | 20influence of this product. KEEP THIS PRODUCT AWAY FROM CHILDREN.''; and (12) |
|---|
| 48 | 48 | | 21comprehensive prominent rotating health warnings, based on the best available research on what |
|---|
| 49 | 49 | | 22constitutes effective warnings for transmitting knowledge and achieving behavior change from |
|---|
| 50 | 50 | | 23tobacco and cannabis warning research, including pictorial warnings if supported. These |
|---|
| 51 | 51 | | 24regulations shall be periodically updated based on emerging science on cannabis and on warning |
|---|
| 52 | 52 | | 25communication best practices. These warnings must also include the increased risk of |
|---|
| 53 | 53 | | 26cannabinoid hyperemesis syndrome, cannabis use disorder, mood disorders, psychosis described |
|---|
| 54 | 54 | | 27as paranoia, hallucinations, delusions, schizophrenia , and suicidal thoughts with use of THC- |
|---|
| 55 | 55 | | 28containing marijuana products, especially when initiated young, used frequently, and/or with use |
|---|
| 56 | 56 | | 29of products containing more than 10% THC. |
|---|